Bausch Health Companies Inc. Gain (Loss) on Extinguishment of Debt
Bausch Health Companies Inc. (BHC) reported Gain (Loss) on Extinguishment of Debt of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-07-30
- Bausch Health Companies Inc. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. gain (loss) on extinguishment of debt for the quarter ending 2026-03-31 was -$1.00M.
- Bausch Health Companies Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was -$19.00M.
- Bausch Health Companies Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $3.00M.
- Bausch Health Companies Inc. gain (loss) on extinguishment of debt for fiscal 2025 was $162.00M, a 604.35% increase from fiscal 2024.
- Bausch Health Companies Inc. gain (loss) on extinguishment of debt for fiscal 2024 was $23.00M, a 2200.00% increase from fiscal 2023.
- Bausch Health Companies Inc. gain (loss) on extinguishment of debt for fiscal 2023 was $1.00M, a 99.89% decline from fiscal 2022.
- Bausch Health Companies Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $875.00M.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt as first filed | Gain (Loss) on Extinguishment of Debt 1 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 6 month as first filed | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-30 | -$1.00M 10-Q · filed 2026-07-30 | -$20.00M derived: sum of 3 quarters · filed 2026-07-30 | -$17.00M derived: sum of 4 quarters · filed 2026-07-30 | |||||||
| 2026-03-31 | -$1.00M 10-Q · filed 2026-04-30 | -$20.00M derived: sum of 2 quarters · filed 2026-04-30 | -$17.00M derived: sum of 3 quarters · filed 2026-04-30 | $161.00M derived: sum of 4 quarters · filed 2026-07-30 | |||||||
| 2025-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$16.00M derived: sum of 2 quarters · filed 2026-02-19 | $162.00M derived: sum of 3 quarters · filed 2026-07-30 | $162.00M 10-K · filed 2026-02-19 | |||||||
| 2025-09-30 | $3.00M 10-Q · filed 2025-10-30 | $181.00M derived: sum of 2 quarters · filed 2026-07-30 | $181.00M 10-Q · filed 2025-10-30 | $181.00M derived: sum of 4 quarters · filed 2026-07-30 | |||||||
| 2025-06-30 | $178.00M 10-Q · filed 2026-07-30 | $178.00M 10-Q · filed 2026-07-30 | $178.00M derived: sum of 3 quarters · filed 2026-07-30 | $178.00M derived: sum of 4 quarters · filed 2026-07-30 | |||||||
| 2025-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | $0.00 derived: sum of 3 quarters · filed 2026-04-30 | $12.00M derived: sum of 4 quarters · filed 2026-04-30 | |||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $12.00M derived: sum of 3 quarters · filed 2026-02-19 | $23.00M 10-K · filed 2026-02-19 | |||||||
| 2024-09-30 | $0.00 10-Q · filed 2025-10-30 | $12.00M derived: sum of 2 quarters · filed 2025-10-30 | $23.00M 10-Q · filed 2025-10-30 | $24.00M derived: sum of 4 quarters · filed 2026-02-19 | |||||||
| 2024-06-30 | $12.00M 10-Q · filed 2025-07-31 | $23.00M 10-Q · filed 2025-07-31 | $24.00M derived: sum of 3 quarters · filed 2026-02-19 | $24.00M derived: sum of 4 quarters · filed 2026-02-19 | |||||||
| 2024-03-31 | $11.00M 10-Q · filed 2025-05-01 | $12.00M derived: sum of 2 quarters · filed 2026-02-19 | $12.00M derived: sum of 3 quarters · filed 2026-02-19 | $12.00M derived: sum of 4 quarters · filed 2026-02-19 | |||||||
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.00M derived: sum of 2 quarters · filed 2026-02-19 | $1.00M derived: sum of 3 quarters · filed 2026-02-19 | $1.00M 10-K · filed 2026-02-19 | |||||||
| 2023-09-30 | $0.00 10-Q · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | $192.00M derived: sum of 4 quarters · filed 2025-02-20 | |||||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $192.00M derived: sum of 3 quarters · filed 2025-02-20 | $762.00M derived: sum of 4 quarters · filed 2025-02-20 | |||||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $192.00M derived: sum of 2 quarters · filed 2025-02-20 | $762.00M derived: sum of 3 quarters · filed 2025-02-20 | $875.00M derived: sum of 4 quarters · filed 2025-02-20 | |||||||
| 2022-12-31 | $192.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $762.00M derived: sum of 2 quarters · filed 2025-02-20 | $875.00M derived: sum of 3 quarters · filed 2025-02-20 | $875.00M 10-K · filed 2025-02-20 | |||||||
| 2022-09-30 | $570.00M 10-Q · filed 2023-11-02 | $683.00M derived: sum of 2 quarters · filed 2023-11-02 | $683.00M 10-Q · filed 2023-11-02 | $683.00M derived: sum of 4 quarters · filed 2024-02-22 | |||||||
| 2022-06-30 | -$63.00M 10-Q · filed 2023-11-02 | $113.00M 10-Q · filed 2023-08-03 | $113.00M 10-Q · filed 2023-08-03 | $113.00M derived: sum of 3 quarters · filed 2024-02-22 | $101.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||||
| 2022-05-10 | -$64.00M 10-K · filed 2025-02-20 | -$63.00M 10-Q · filed 2022-08-09 | |||||||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | -$12.00M derived: sum of 3 quarters · filed 2024-02-22 | -$57.00M derived: sum of 4 quarters · filed 2024-02-22 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$12.00M derived: sum of 2 quarters · filed 2024-02-22 | -$57.00M derived: sum of 3 quarters · filed 2024-02-22 | -$62.00M 10-K · filed 2024-02-22 | |||||||
| 2021-09-30 | -$12.00M 10-Q · filed 2022-11-03 | -$57.00M derived: sum of 2 quarters · filed 2022-11-03 | -$62.00M 10-Q · filed 2022-11-03 | -$70.00M derived: sum of 4 quarters · filed 2023-02-23 | |||||||
| 2021-06-30 | -$45.00M 10-Q · filed 2022-08-09 | -$50.00M 10-Q · filed 2022-08-09 | -$58.00M derived: sum of 3 quarters · filed 2023-02-23 | -$58.00M derived: sum of 4 quarters · filed 2023-02-23 | |||||||
| 2021-06-08 | -$38.00M 10-K · filed 2024-02-22 | ||||||||||
| 2021-03-31 | -$5.00M 10-Q · filed 2022-05-10 | -$13.00M derived: sum of 2 quarters · filed 2023-02-23 | -$13.00M derived: sum of 3 quarters · filed 2023-02-23 | -$40.00M derived: sum of 4 quarters · filed 2023-02-23 | |||||||
| 2020-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$8.00M derived: sum of 2 quarters · filed 2023-02-23 | -$35.00M derived: sum of 3 quarters · filed 2023-02-23 | -$59.00M 10-K · filed 2023-02-23 | |||||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-02 | -$27.00M derived: sum of 2 quarters · filed 2021-11-02 | -$51.00M 10-Q · filed 2021-11-02 | -$53.00M derived: sum of 4 quarters · filed 2022-05-11 | |||||||
| 2020-06-30 | -$27.00M 10-Q · filed 2021-08-03 | -$51.00M 10-Q · filed 2021-08-03 | -$53.00M derived: sum of 3 quarters · filed 2022-05-11 | -$53.00M derived: sum of 4 quarters · filed 2022-05-11 | |||||||
| 2020-05-26 | -$27.00M 10-K · filed 2023-02-23 | ||||||||||
| 2020-03-31 | -$24.00M 10-Q · filed 2021-05-04 | -$26.00M derived: sum of 2 quarters · filed 2022-05-11 | -$26.00M derived: sum of 3 quarters · filed 2022-05-11 | -$59.00M derived: sum of 4 quarters · filed 2022-05-11 | |||||||
| 2019-12-31 | -$2.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | -$2.00M derived: sum of 2 quarters · filed 2022-05-11 | -$35.00M derived: sum of 3 quarters · filed 2022-05-11 | -$42.00M 8-K · filed 2022-05-11 | |||||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-03 | -$33.00M derived: sum of 2 quarters · filed 2020-11-03 | -$40.00M 10-Q · filed 2020-11-03 | -$84.00M derived: sum of 4 quarters · filed 2021-05-04 | |||||||
| 2019-06-30 | -$33.00M 10-Q · filed 2020-08-06 | -$40.00M 10-Q · filed 2020-08-06 | -$84.00M derived: sum of 3 quarters · filed 2021-05-04 | -$84.00M derived: sum of 4 quarters · filed 2021-05-04 | |||||||
| 2019-03-31 | -$7.00M 10-Q · filed 2020-05-07 | -$51.00M derived: sum of 2 quarters · filed 2021-05-04 | -$51.00M derived: sum of 3 quarters · filed 2021-05-04 | -$99.00M derived: sum of 4 quarters · filed 2021-05-04 | |||||||
| 2019-03-08 | -$8.00M 8-K · filed 2022-05-11 | -$7.00M 10-Q · filed 2019-05-06 | |||||||||
| 2018-12-31 | -$44.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | -$44.00M derived: sum of 2 quarters · filed 2021-05-04 | -$92.00M derived: sum of 3 quarters · filed 2021-05-04 | -$119.00M 8-K · filed 2021-05-04 | |||||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-04 | -$48.00M derived: sum of 2 quarters · filed 2019-11-04 | -$75.00M 10-Q · filed 2019-11-04 | -$132.00M derived: sum of 4 quarters · filed 2020-02-19 | |||||||
| 2018-06-30 | -$48.00M 10-Q · filed 2019-08-06 | -$75.00M 10-Q · filed 2019-08-06 | -$132.00M derived: sum of 3 quarters · filed 2020-02-19 | -$133.00M derived: sum of 4 quarters · filed 2020-02-19 | |||||||
| 2018-03-31 | -$27.00M 10-Q · filed 2019-05-06 | -$84.00M derived: sum of 2 quarters · filed 2020-02-19 | -$85.00M derived: sum of 3 quarters · filed 2020-02-19 | -$85.00M derived: sum of 4 quarters · filed 2020-02-19 | |||||||
| 2017-12-31 | -$57.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$58.00M derived: sum of 2 quarters · filed 2020-02-19 | -$58.00M derived: sum of 3 quarters · filed 2020-02-19 | -$122.00M 10-K · filed 2020-02-19 | |||||||
| 2017-09-30 | -$1.00M 10-Q · filed 2018-11-06 | -$1.00M derived: sum of 2 quarters · filed 2018-11-06 | -$65.00M 10-Q · filed 2018-11-06 | -$65.00M derived: sum of 4 quarters · filed 2019-02-20 | |||||||
| 2017-08-15 | -$1.00M 8-K · filed 2018-08-10 | ||||||||||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-07 | -$64.00M 10-Q · filed 2018-08-07 | -$64.00M derived: sum of 3 quarters · filed 2019-02-20 | -$64.00M derived: sum of 4 quarters · filed 2019-02-20 | |||||||
| 2017-03-31 | -$64.00M 10-Q · filed 2018-05-08 | -$64.00M derived: sum of 2 quarters · filed 2019-02-20 | -$64.00M derived: sum of 3 quarters · filed 2019-02-20 | -$64.00M derived: sum of 4 quarters · filed 2019-02-20 | |||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $0.00 derived: sum of 2 quarters · filed 2019-02-20 | $0.00 derived: sum of 3 quarters · filed 2019-02-20 | $0.00 10-K · filed 2019-02-20 | |||||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 4 quarters · filed 2018-08-10 | |||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | $0.00 derived: sum of 3 quarters · filed 2018-08-10 | $0.00 derived: sum of 4 quarters · filed 2018-08-10 | |||||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-08-10 | $0.00 derived: sum of 3 quarters · filed 2018-08-10 | $0.00 derived: sum of 4 quarters · filed 2018-08-10 | |||||||
| 2015-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $0.00 derived: sum of 2 quarters · filed 2018-08-10 | $0.00 derived: sum of 3 quarters · filed 2018-08-10 | -$20.00M 8-K · filed 2018-08-10 | |||||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | -$20.00M 10-Q · filed 2016-11-09 | -$56.30M derived: sum of 4 quarters · filed 2017-03-01 | |||||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | -$20.00M 10-Q · filed 2016-08-09 | -$56.30M derived: sum of 3 quarters · filed 2017-03-01 | -$56.30M derived: sum of 4 quarters · filed 2017-03-01 | |||||||
| 2015-03-31 | -$20.00M 10-Q · filed 2016-06-07 | -$56.30M derived: sum of 2 quarters · filed 2017-03-01 | -$56.30M derived: sum of 3 quarters · filed 2017-03-01 | -$56.30M derived: sum of 4 quarters · filed 2017-03-01 | |||||||
| 2014-12-31 | -$36.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$36.30M derived: sum of 2 quarters · filed 2017-03-01 | -$36.30M derived: sum of 3 quarters · filed 2017-03-01 | -$130.00M 10-K · filed 2017-03-01 | -$129.60M 10-K · filed 2015-02-25 | ||||||
| 2014-09-30 | $0.00 10-Q · filed 2015-10-26 | $0.00 derived: sum of 2 quarters · filed 2015-10-26 | -$93.70M 10-Q · filed 2015-10-26 | -$129.40M derived: sum of 4 quarters · filed 2017-03-01 | |||||||
| 2014-06-30 | $0.00 10-Q · filed 2015-07-28 | -$93.70M 10-Q · filed 2015-07-28 | -$129.40M derived: sum of 3 quarters · filed 2017-03-01 | -$137.60M derived: sum of 4 quarters · filed 2017-03-01 | |||||||
| 2014-03-31 | -$94.00M 10-K · filed 2017-03-01 | -$93.70M 10-Q · filed 2014-05-09 | -$129.40M derived: sum of 2 quarters · filed 2017-03-01 | -$137.60M derived: sum of 3 quarters · filed 2017-03-01 | -$137.60M derived: sum of 4 quarters · filed 2017-03-01 | ||||||
| 2013-12-31 | -$35.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -$43.60M derived: sum of 2 quarters · filed 2016-04-29 | -$43.60M derived: sum of 3 quarters · filed 2016-04-29 | -$65.00M 10-K · filed 2016-04-29 | -$65.01M 10-K · filed 2014-02-28 | ||||||
| 2013-09-30 | -$8.20M 10-Q · filed 2014-10-24 | -$8.16M 10-Q · filed 2013-11-01 | -$8.20M derived: sum of 2 quarters · filed 2014-10-24 | -$29.60M 10-Q · filed 2014-10-24 | -$29.54M 10-Q · filed 2013-11-01 | -$47.24M derived: sum of 4 quarters · filed 2015-02-25 | |||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-01 | -$21.40M 10-Q · filed 2014-08-01 | -$21.38M 10-Q · filed 2013-08-07 | -$39.05M derived: sum of 3 quarters · filed 2015-02-25 | -$41.37M derived: sum of 4 quarters · filed 2015-02-25 | ||||||
| 2013-03-31 | -$21.40M 10-Q · filed 2014-05-09 | -$21.38M 10-Q · filed 2013-05-03 | -$39.05M derived: sum of 2 quarters · filed 2015-02-25 | -$41.37M derived: sum of 3 quarters · filed 2015-02-25 | -$41.37M derived: sum of 4 quarters · filed 2015-02-25 | ||||||
| 2012-12-31 | -$17.64M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$19.97M derived: sum of 2 quarters · filed 2015-02-25 | -$19.97M derived: sum of 3 quarters · filed 2015-02-25 | -$20.10M 10-K · filed 2015-02-25 | -$20.08M 10-K · filed 2013-02-28 | ||||||
| 2012-09-30 | -$2.32M 10-Q · filed 2013-11-01 | -$2.32M derived: sum of 2 quarters · filed 2013-11-01 | -$2.46M 10-Q · filed 2013-11-01 | -$5.97M derived: sum of 4 quarters · filed 2014-02-28 | |||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-07 | -$133.00K 10-Q · filed 2013-08-07 | -$3.65M derived: sum of 3 quarters · filed 2014-02-28 | -$13.97M derived: sum of 4 quarters · filed 2014-02-28 | |||||||
| 2012-03-31 | -$133.00K 10-Q · filed 2013-05-03 | -$3.65M derived: sum of 2 quarters · filed 2014-02-28 | -$13.97M derived: sum of 3 quarters · filed 2014-02-28 | -$28.71M derived: sum of 4 quarters · filed 2014-02-28 | |||||||
| 2011-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$13.83M derived: sum of 2 quarters · filed 2014-02-28 | -$28.58M derived: sum of 3 quarters · filed 2014-02-28 | -$36.84M 10-K · filed 2014-02-28 | |||||||
| 2011-09-30 | -$10.31M 10-Q · filed 2012-11-05 | -$25.06M derived: sum of 2 quarters · filed 2012-11-05 | -$33.33M 10-Q · filed 2012-11-05 | ||||||||
| 2011-06-30 | -$14.75M 10-Q · filed 2012-08-03 | -$23.01M 10-Q · filed 2012-08-03 | |||||||||
| 2011-03-31 | -$8.26M 10-Q · filed 2012-05-04 | ||||||||||
| 2010-12-31 | -$32.41M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |